跳到主要內容區塊
:::

整合醫學科

Print
    曾瑞成 TSENG Jui-Cheng
    曾瑞成 TSENG Jui-Cheng
    看診科別
    現職
    • 整合醫學科主任
    主治專長
    • 全身性紅斑性狼瘡
    • 類風濕性關節炎
    • 硬皮症
    • 僵直性脊椎炎
    • 過敏與自體免疫風濕疾病
    學歷
    • 陽明醫學院醫學系
    • 美國史丹佛大學研究員
    經歷
    • 高雄榮總內科部住院醫師
    • 高雄榮總免疫風濕科總醫師
    • 高雄榮總主治醫師
    • 過敏免疫風濕科科主任
    代表著作
    • 1. Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjogren’s syndrome: results from a randomized, double-blind, placebo-controlled
    • Phase 2 trial.
    • Thomas Dorner, Martin Kaul, Antonio Szanto, Jui-Cheng Tseng, Athena S Papas,
    • Llona pylvaenaeinen, Malika Hanser, Nasri Abdallah, Andrea Grioni, Aida Santos Da Costa, Enrico Ferrero, Peter Gergely, Rainer Hillenbrand, Alexandre Avrameas, Bruno Cenni, Richard M Siegel.
    • Annals of the Rheumatic Diseases, 2023
    • 0:1-12. doi:10.1136/ard-2023-224691
    • 2. Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis.
    • Kuang-Hui Yu, Hsin-Hua Chen, Tien-Tsai Cheng, Yeong-Jian Jan, Meng-Yu Weng, Yeong-Jang Lin, Hung-An Chen, Jui-Cheng Tseng, Kuang-Yung Huang, Ko-Jen Li, Yu-Jih Su, Pui-Ying Leong, Wen-Chan Tsai, Joung-Liang La and Der Yuan Chen
    • Medicine (Baltimore). 2022 Jan 7. doi: 10.1097/MD.0000000000028501
    • 3. Peficitinib (ASP015K) in Taiwanese patients with rheumatoid arthritis and inadequate response to conventional disease-modifying antirheumatic drugs
    • in a phase 3 trial (RAJ3).
    • Yi-Hsing Chen, Yoshiya Tanaka, Tsutomu Takeuchi, James Cheng-Chung Wei,
    • Yao-Fan Fang, Jui-Cheng Tseng, Hiroyuki Izutsu, Yuichiro Kaneko
    • Formosan Journal of Rheumatology. 2021
    • 35:9-23
    • 4. Increased risk of Sjogren’s syndrome on patients with obsessive-compulsive disorder: A nationwide population-based cohort study.
    • Chang YJ, Tseng JC, Leong PY, Wang YH, James Wei CC.
    • International Journal of Environmental Research and Public Health.
    • 2021 Jun
    • 18:5936.
    • 5. 1. Yu HC, Tseng JC, Lu LY, Hu JC, Chen YH, Hsu CL, Wu PC, Mar GY, Lin KH. Monitoring by viral load and quantitative hepatitis B surface antigen in patients with hepatitis B virus infection receiving immunosuppressive therapy.
    • Eur J Gastroenterol Hepatol. 2021, 33:107-113.
    :::